XPEV - Hot Stocks: NVAX rises; MNRA falls; ABVC becomes a meme; CRWD downgrade; XPEV deliveries
The makers of COVID vaccines were in focus during Monday's midday action. Novavax (NASDAQ:NVAX) saw buying interest after receiving its first emergency-use clearance. At the same time, rival Moderna (NASDAQ:MRNA) lost ground on word that its vaccine won't be approved for use in adolescents before the end of the year. In other news, electric vehicle maker XPeng (NYSE:XPEV) climbed in intraday trading after its EV deliveries for the latest month more than tripled from last year. Meanwhile, ABVC Biopharma (NASDAQ:ABVC) skyrocketed after getting heavy retail investor attention on online forums. Turning to one of the day's biggest decliners, CrowdStrike (NASDAQ:CRWD) showed weakness following a bearish analyst note, as the company faces increased competition in the cybersecurity space. Gainers Novavax (NVAX) received a boost on news that Indonesia had approved its COVID vaccine for emergency use in the country. This marked the product's first emergency use clearance, sparking a midday advance
For further details see:
Hot Stocks: NVAX rises; MNRA falls; ABVC becomes a meme; CRWD downgrade; XPEV deliveries